Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?

Journal of Nuclear Cardiology

Volumn 11, Issue 5, 2004, Pages 578-586

  Romero Farina, Guillermo ^a   Candell Riera, Jaume ^a   Galve, Enrique ^a   Armadans, Lluís ^a   Ramos, Francisca ^a   Castell, Joan ^a   Aguadé, Santiago ^a   Nogales, Juan M ^a   Soler Soler, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Hypertrophic cardiomyopathy; Myocardial perfusion single photon emission computed tomography; Prognosis; Radionuclide ventriculography

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DISOPYRAMIDE; TETROFOSMIN TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIASTOLE; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIOISOTOPE VENTRICULOGRAPHY; SCINTIANGIOGRAPHY; SCINTILLATION CAMERA; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SURVIVAL RATE; SYNCOPE; TIME;

CARDIOMYOPATHY, HYPERTROPHIC; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIONUCLIDE ANGIOGRAPHY; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 5044248289     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2004.05.008     Document Type: Article

References (39)

1. K.R. Chien Genomic circuits and the integrative biology of cardiomyopathies Eur Heart J 3 Suppl L 2001 3-9
2. B.J. Maron R.O. Bonow R.O. Cannon M.B. Leon S.E. Epstein Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology and therapy N Engl J Med 316 1987 780-789
3. E.D. Wigle H. Rakowski B.P. Kimball W.G. Williams Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680-1692
4. B.J. Maron S.A. Casey L.C. Poliac T.E. Gohman A.K. Almquist D.M. Aeppli Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650-655
5. J.M. Maron I. Olivotto P. Spirito S.A. Casey P. Bellone T.E. Gohman et al. Epidemiology of hypertrophic cardiomyopathy-related death. Revised in a large non-referral-based patient population Circulation 102 2000 858-864
6. W.J. McKenna J. Deanfield A. Faruqui D. England C. Oakley J. Goodwin Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features Am J Cardiol 47 1981 532-538
7. L. Monserrat P.M. Elliot J.R. Gimeno S. Sharma M. Penas-Lado W.J. McKenna Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients J Am Coll Cardiol 42 2003 873-879
8. Y. Koga K. Itaya H. Toshima Prognosis in hypertrophic cardiomyopathy Am Heart J 108 1984 351-359
9. F. Cecchi I. Olivotto R. et al. Gistri Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027-1035
10. P. Spirito C. Rapezzi C. Autore P. Bruzzi P. Bellone P. Ortolani et al. Prognosis in asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia Circulation 90 1994 2743-2747
11. N. Sadoul K. Prasad P.M. Elliott S. Bannerjee M.P. Frenneaux W.J. McKenna Prospective prognosis assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy Circulation 96 1997 2987-2991
12. H. Ikeda S. Maki N. Yoshida T. Murohara H. Adachi Y Koga Predictors of death from congestive heart failure in hypertrophic cardiomyopathy Am J Cardiol 83 1999 1280-1283
13. P. Spirito P. Bellone K.M. Harris P. Bernabo P. Bruzzi B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778-1785
14. J. Candell Riera G. Romero Farina E. Galve Basilio J. Palet Balart L. Armadans M Dolores Reina Value of Doppler-echocardiography in the prognosis and follow up of hypertrophic myocardiopathy [in Spanish] Rev Esp Cardiol 54 2001 7-15
15. B.J. Maron I. Olivotto P. Bellone M.R. Conte F. Cecchi B.P Flygenring et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 301-307
16. M.J.M. Kofflard F.J. Ten Cate C. van der Lee R.T. van Domburg Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration J Am Coll Cardiol 41 2003 987-993
17. T.W. von Dohlen L.M. Prisant M.J. Frank Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy Am J Cardiol 64 1989 498-503
18. V. Dilsizian R.O. Bonow S.E. Epstein L. Fananapazir Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy J Am Coll Cardiol 22 1993 796-804
19. M. Yamada P.M. Elliot J.C. Kaski K. Prasad J.N. Gane C.M Lowe et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy Eur Heart J 19 1998 500-507
20. T. Chikamori D. Shaughan J.D. Poloniecki M.J. Myers J.P. Lavender W.J. McKenna Prognosis significance of radionuclide-assessed diastolic function in hypertrophic cardiomyopathy Am J Cardiol 65 1990 478-482
21. B.J. Maron J.S. Gottdiener S.E. Epstein Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients Am J Cardiol 48 1981 418-428
22. 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease J Am Coll Cardiol 29 1997 531-536
23. M.D. Cerqueira N.J. Weissman V. Dilsizian A.K. Jacobs S. Kaul W.K Laskey Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539-542
24. B.L. Zaret A. Battler H.J. Berger M.M. Bodenheimer J.S. Borer M. Brochier et al. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Nuclear Cardiology Eur Heart J 5 1984 850-863
25. F. Cecchi I. Olivotto A. Montereggi G. Santoro A. Dolara B.J. Maron Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population J Am Coll Cardiol 26 1995 1529-1536
26. SPSS: Base 7.5 for Windows User's guide 1997 SPSS Inc Chicago
27. R.O. Cannon III V. Dilsizian P.T. O'Gara J.E. Udelson W.H. Schenke A. Quyyumi et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy Circulation 83 1991 1660-1667
28. P.M. Elliot G.M.C. Rosano J.S. Gill P.A. Poole-Wilson J.C. Kaski W.J. McKenna Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy and chest pain Heart 75 1996 179-183
29. G. Romero-Farina J. Candell-Riera O. Pereztol-Valdś S. Aguade-Bruix J. Castell-Conesa L. Armadans et al. Myocardial SPET in hypertrophic cardiomyopathy [in Spanish] Rev Esp Cardiol 53 2000 1589-1595
30. M. Tanaka H. Fujiwara T. Onodera D.J. Wu Y. Hamashima C. Kawai Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy Br Heart J 55 1986 575-581
31. K.A. Rubin J. Morrison M.B. Padnick A.J. Binder S. Chiaramida D. Margouleff et al. Idiopathic hypertrophic subaortic stenosis: evaluation of anginal symptoms with thallium-201 myocardial imaging Am J Cardiol 44 1979 1040-1045
32. D. Pitcher R. Wainwright M. Maisey P. Curry E. Sowton Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial imaging Br Heart J 44 1980 650-656
33. P.T. O'Gara R.O. Bonow B.J. Maron B.A. Damske A. Van Lingen S.L. Bacharach et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography Circulation 76 1987 1214-1223
34. G. Romero-Farina J. Candell-Riera O. Pereztol-Valdés J. Castell S. Aguade E. Galve et al. Myocardial perfusion SPECT and isotopic ventriculography in obstructive and non-obstructive hypertrophic myocardiopathy [in Spanish] Rev Esp Med Nucl 20 2001 530-536
35. L. Choudhury H. Mahrholdt A. Wagner K.M. Choi M.D. Elliott F.J. Klocke et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156-2164
36. P. Hanrath D. Mathey R. Montz U. Thiel H. Vorbringer W. Kupper et al. Myocardial thallium-201 imaging in hypertrophic obstructive cardiomyopathy Eur Heart J 2 1981 177-185
37. J.E. Udelson R.O. Bonow P.T. O'Gara B.J. Maron A. Van Lingen S.L. Bacharach et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy Circulation 79 1989 1052-1060
38. R.O. Bonow D.R. Rosing S.L. Bacharach M.V. Green K.M. Kent L.C. Lipson et al. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy Circulation 64 1981 787-796
39. S. Betocchi R.O. Bonow S.L. Bacharach D.R. Rosing B.J. Maron M.V. Green Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography J Am Coll Cardiol 7 1986 74-81